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Editors’ NotesRedifferentiation of iPSCs, and Back Again
Two papers presented in this issue offer important methodological tools that should prove valuable in overcom-
ing some of the challenges that remain for future application of induced pluripotent stem cell (iPSC) technology.
Maherali et al. use inducible retrovirus constructs to derive iPSCs from human adult fibroblasts and keratino-
cytes. Remarkably, the progeny of the iPSCs, once differentiated to mature lineages, can be reversed back
to a pluripotent state at very high efficiencies following reactivation of the latent reprogramming constructs.
Hockemeyer et al. present similar success in deriving these ‘‘secondary’’ iPSC colonies, also by targeting
human fibroblasts with inducible reprogramming vectors. Of note, both groups manage to reduce the time
required to obtain pluripotent colonies, suggesting that some cell populations may prove particularly amenable
to transient reprogramming strategies, and offering hope that the requirement for viral vectors may soon be
overcome. The combined results from the Hochedlinger and Jaenisch research groups also underscore the
speed with which the field is advancing and provide mutually supportive validation of important new findings
in this technically challenging discipline.
Everything in Context
Considerable attention, both in the mainstream media and in the scientific press, has been paid to the recent Hastings report from
R. Streiffer that reveals that many, if not all, hESC lines available for NIH funding were not, in fact, obtained according to currently
accepted conditions of ethical consent. In this issue, a Letter from prominent bioethicists J. Sugarman and A. Siegel outlines their
advice to scientists and members of ethical oversight committees about ascertaining when the provenance of a given hESC line
is consistent with its use in a particular research endeavor. The authors emphasize that the context in which the lines were generated
must be considered relative to the specific use being proposed. The use of hESC lines, in research and potential clinical applications,
was also a significant theme of the recent ISSCR annual meeting in Philadelphia. In the ISSCR pages, G. Keller and colleagues
provide a Meeting Report synthesizing the range of exciting scientific advances that were reported over the four-day conference.
Neurogenesis to the Rescue
With all the talk about hESCs and putative clinical interventions based on transplanted populations, it can be easy to lose sight of the
therapeutic potential of endogenous stem and progenitor cells. A Profile article from K.Wong outlines the approaches taken by three
different commercial ventures, each based on the premise of working with cells already present in the human brain. While the impli-
cations of these efforts are exciting, the article also cautions that the suitability of human experimentation at this relatively early date
remains controversial, even for compounds that appear safe for othermedical indications. Studies into the rescue of newly generated
neurons in animal models are making great strides, however. In her Commentary article, T. Shors describes an extensive body of
work demonstrating that neurogenesis is intimately linked with learning and memory. The precise nature of the impact of each pro-
cess on the other remains to be clarified, but it is now evident that different learning tasks can rescue new neurons from death in adult
rodents. She proposes that clinical research programs should consider potential external and behavioral modifiers of endogenous
stem cells, in addition to chemical modifiers and transplantation paradigms.
Stem Cells and Vessels Coming Together
Four papers in this issue provide insight into the niche organization of two different stem cell populations. In one case, three papers
(Mirzadeh et al., Shen et al., and Tavazoie et al.) examine the architecture and organization of the neural stem cell (NSC) niche in the
adult rodent. This particular niche and, in fact, the identity of the stem cell population itself have been
the subject of some controversy in recent years, as discussed in the accompanying Preview article
by R. Gilbertson. The new studies show that NSCs reside in contact with both the ventricle and
vasculature and are distinct from ependymal populations in the area. The proximity of stem cells
to blood vessels is also highlighted in a fourth paper from Peault and colleagues, who found that
mesenchymal stromal cells (MSCs) with stem cell properties exist as a pericyte population in a
diverse array of human tissues. You can read more about the implications of these findings in a
Preview article from A. Caplan, or listen to Dr. Peault himself in an interview that will appear in
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